Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sirolimus in Treating Patients With Angiomyolipoma of the Kidney

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2008 by National Cancer Institute (NCI).
Recruitment status was:  Active, not recruiting
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00126672
First received: August 2, 2005
Last updated: February 1, 2010
Last verified: October 2008